Solventum Future Growth
Future criteria checks 2/6
Solventum is forecast to grow earnings and revenue by 6% and 0.9% per annum respectively. EPS is expected to grow by 4.7% per annum. Return on equity is forecast to be 26.9% in 3 years.
Key information
6.0%
Earnings growth rate
4.7%
EPS growth rate
| Medical Equipment earnings growth | 14.2% |
| Revenue growth rate | 0.9% |
| Future return on equity | 26.9% |
| Analyst coverage | Good |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8,405 | 730 | 900 | 1,253 | 7 |
| 12/31/2025 | 8,260 | 662 | 656 | 1,135 | 9 |
| 12/31/2024 | 8,229 | 545 | 755 | 1,173 | 7 |
| 9/30/2024 | 8,215 | 720 | 1,172 | 1,513 | N/A |
| 6/30/2024 | 8,207 | 1,058 | 1,523 | 1,837 | N/A |
| 3/31/2024 | 8,202 | 1,290 | 1,521 | 1,848 | N/A |
| 12/31/2023 | 8,197 | 1,346 | 1,625 | 1,915 | N/A |
| 9/30/2023 | 8,166 | 1,381 | 1,530 | 1,814 | N/A |
| 6/30/2023 | 8,101 | 1,256 | 1,542 | 1,817 | N/A |
| 3/31/2023 | 8,083 | 1,286 | 1,560 | 1,820 | N/A |
| 12/31/2022 | 8,130 | 1,343 | 1,428 | 1,679 | N/A |
| 12/31/2021 | 8,171 | 1,460 | 1,925 | 2,202 | N/A |
| 12/31/2020 | 7,281 | 1,138 | 1,755 | 2,026 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KB7's forecast earnings growth (6% per year) is above the savings rate (1%).
Earnings vs Market: KB7's earnings (6% per year) are forecast to grow slower than the German market (20.8% per year).
High Growth Earnings: KB7's earnings are forecast to grow, but not significantly.
Revenue vs Market: KB7's revenue (0.9% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: KB7's revenue (0.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KB7's Return on Equity is forecast to be high in 3 years time (26.9%)